Exenatide, sold under the brand name Byetta among others, is a medication used to treat type 2 diabetes. It is used together with diet, exercise, and...
24 KB (2,087 words) - 16:42, 11 May 2024
Amylin Pharmaceuticals (section Byetta (Exenatide))
produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release). In 1987, Amylin Pharmaceuticals was co-founded...
14 KB (1,253 words) - 22:25, 14 August 2024
injection. Exenatide also slows the emptying of the stomach and causes a decrease in appetite, contributing to weight loss. The antidiabetic exenatide (Byetta)...
47 KB (5,523 words) - 05:24, 13 September 2024
the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered...
50 KB (5,222 words) - 18:06, 23 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
44 KB (3,493 words) - 05:47, 15 September 2024
suggested 1–3 years use of glucagon like peptide-1 receptor agonists like exenatide, liraglutide and dulaglutide may be linked with increased occurrence of...
66 KB (5,428 words) - 08:55, 26 September 2024
pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated with pancreatitis by promoting inflammation...
42 KB (4,143 words) - 15:37, 20 September 2024
glucose; the substance is now synthesised for use in the anti-diabetes drug exenatide (Byetta). Another toxin from Gila monster saliva has been studied for...
138 KB (14,817 words) - 18:01, 28 September 2024
Some patients develop anti-drug antibodies, which are more common with exenatide (the antibodies were detectable in a third or more of patients) than other...
38 KB (3,935 words) - 21:33, 20 September 2024
glucose; the substance is now synthesized for use in the anti-diabetes drug exenatide (Byetta). Another toxin from Gila monster saliva has been studied for...
69 KB (6,687 words) - 01:25, 5 September 2024
Venoms in medicine (section Exenatide)
the risk of thrombosis. It is an antagonist of glycoprotein IIb/IIIa. Exenatide is a 39-amino-acid peptide that is a synthetic version of exendin-4, a...
11 KB (1,302 words) - 19:09, 20 November 2023
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
151 KB (14,429 words) - 05:01, 15 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
41 KB (3,452 words) - 21:10, 4 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
56 KB (5,566 words) - 04:53, 25 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
79 KB (6,430 words) - 02:40, 22 September 2024
peptide-2 Type 2 diabetes GLP-1 receptor agonists : albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide and semaglutide, the latter of...
26 KB (3,386 words) - 20:05, 10 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
53 KB (4,960 words) - 03:28, 26 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
3 KB (184 words) - 13:53, 14 June 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
86 KB (7,963 words) - 18:33, 12 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
42 KB (3,798 words) - 03:37, 17 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
31 KB (2,634 words) - 22:05, 30 August 2024
principally act as agonists of the GLP-1 receptor and are thus insulinotropic. Exenatide was the first drug in this class to be used in the treatment of type 2...
7 KB (885 words) - 12:53, 10 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
29 KB (2,960 words) - 20:56, 4 September 2024
Diabetes management (section Exenatide)
S. Food and Drug Administration (FDA) has approved a treatment called Exenatide, based on the saliva of a Gila monster, to control blood sugar in patients...
101 KB (12,818 words) - 08:03, 17 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
16 KB (1,284 words) - 04:32, 23 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
4 KB (328 words) - 05:24, 6 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
18 KB (1,514 words) - 15:51, 7 June 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
88 KB (8,913 words) - 02:42, 18 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
41 KB (3,673 words) - 18:02, 22 September 2024
Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
25 KB (2,086 words) - 02:24, 16 July 2024